뉴스벤징가
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer
· 발표
기사 요약
Merck's Phase 3 KEYNOTE-C93 trial showed Keytruda improved progression-free survival over chemotherapy in advanced endometrial cancer.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…